David Ferry
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Gastric Cancer Management and Outcomes 33
- Lung Cancer Treatments and Mutations 15
- Oncology 52
- Colorectal Cancer Treatments and Studies 36
- Cancer Immunotherapy and Biomarkers 11
- Co-authors
- Hartmut Glossmann (18 shared papers)Eric Van Cutsem (21 shared papers)David Cunningham (9 shared papers)Jaffer A. Ajani (9 shared papers)Kei Muro (7 shared papers)Atsushi Ohtsu (7 shared papers)A. Göll (7 shared papers)Josep Tabernero (20 shared papers)
- Journals
- Journal of Clinical Oncology (45 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (9 papers)Annals of Oncology (4 papers)Journal of Thoracic Oncology (4 papers)European Journal of Cancer (4 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
David Ferry
126 papers receiving 8.9k citations
David Ferry's Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 3.4k
- Gastroenterology 618
- Pulmonary and Respiratory Medicine 2.9k
- Hepatology 459
- Cardiology and Cardiovascular Medicine 1.1k
Countries citing papers authored by David Ferry
This map shows the geographic impact of David Ferry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ferry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ferry more than expected).
Fields of papers citing papers by David Ferry
This network shows the impact of papers produced by David Ferry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ferry. The network helps show where David Ferry may publish in the future.
Co-authors
The 25 scholars most cited alongside David Ferry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Hit paper breakdown → | 2014 | 1743 |
| 2 | Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen Hit paper breakdown → | 2012 | 992 |
| 3 | Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial Hit paper breakdown → | 2013 | 551 |
| 4 | 1998 | 493 | |
| 5 | 2007 | 408 | |
| 6 | Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study Hit paper breakdown → | 2013 | 382 |
| 7 | 1982 | 252 | |
| 8 | 2011 | 243 | |
| 9 | 1999 | 236 | |
| 10 | 2002 | 216 | |
| 11 | 2014 | 186 | |
| 12 | 1985 | 163 | |
| 13 | 2013 | 161 | |
| 14 | 2015 | 134 | |
| 15 | 2006 | 133 | |
| 16 | 2018 | 124 | |
| 17 | 2017 | 115 | |
| 18 | 1982 | 109 | |
| 19 | 2009 | 96 | |
| 20 | 2009 | 96 |
About David Ferry
David Ferry is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Cellular and Molecular Neuroscience, having authored 126 papers that have together received 9.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (36 papers), Gastric Cancer Management and Outcomes (33 papers), Ion channel regulation and function (17 papers), Lung Cancer Treatments and Mutations (15 papers), Neuroscience and Neuropharmacology Research (11 papers), Gastrointestinal Tumor Research and Treatment (11 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Esophageal Cancer Research and Treatment (10 papers). The work is most often cited by research in Oncology (3.4k citations), Gastroenterology (618 citations), Pulmonary and Respiratory Medicine (2.9k citations), Hepatology (459 citations) and Cardiology and Cardiovascular Medicine (1.1k citations). David Ferry has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Hartmut Glossmann, Eric Van Cutsem, David Cunningham, Jaffer A. Ajani, Kei Muro, Atsushi Ohtsu, A. Göll, Josep Tabernero, H. Wilke and G. Bodoky. Their work appears in journals such as Journal of Clinical Oncology, Naunyn-Schmiedeberg s Archives of Pharmacology, Annals of Oncology, Journal of Thoracic Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.